Ocular Therapeutix
OCUL
OCUL
65 hedge funds and large institutions have $140M invested in Ocular Therapeutix in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 25 increasing their positions, 13 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
11.91% more ownership
Funds ownership: 45.88% → 57.79% (+12%)
6% less funds holding
Funds holding: 69 → 65 (-4)
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
Holders
65
Holding in Top 10
3
Calls
$1.29M
Puts
$622K
Top Buyers
| 1 | +$19.7M | |
| 2 | +$13.5M | |
| 3 | +$7.23M | |
| 4 |
DAM
Deltec Asset Management
New York
|
+$2.42M |
| 5 |
Jennison Associates
New York
|
+$1.94M |
Top Sellers
| 1 | -$279K | |
| 2 | -$267K | |
| 3 | -$219K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$216K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$177K |